chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling of body temperature change, Headache, Migraine, Neck pain, Oropharyngeal pain
Clinical narrative: Severe pain shooting up her neck; Felt hot and cold; Sore throat; Developed a rash on her arm that then spread to the larger area of it; Severe migraine pain; slight headache; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Severe migraine pain), NECK PAIN (Severe pain shooting up her neck), FEELING OF BODY TEMPERATURE CHANGE (Felt hot and cold), OROPHARYNGEAL PAIN (Sore throat) and RASH (Developed a rash on her arm that then spread to the larger area of it) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027B21A and 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEADACHE (slight headache). On 16-Apr-2021, the patient experienced MIGRAINE (Severe migraine pain). On 17-Apr-2021, the patient experienced RASH (Developed a rash on her arm that then spread to the larger area of it). On an unknown date, the patient experienced NECK PAIN (Severe pain shooting up her neck), FEELING OF BODY TEMPERATURE CHANGE (Felt hot and cold) and OROPHARYNGEAL PAIN (Sore throat). At the time of the report, MIGRAINE (Severe migraine pain), NECK PAIN (Severe pain shooting up her neck), FEELING OF BODY TEMPERATURE CHANGE (Felt hot and cold), OROPHARYNGEAL PAIN (Sore throat) and HEADACHE (slight headache) outcome was unknown and RASH (Developed a rash on her arm that then spread to the larger area of it) had not resolved.            No concomitant medication was reported. No treatment medication was reported.  Action taken with the mRNA-1273 vaccine in response to the events was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-080115 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 16-May-2021: Initial additional (TCR) received on 16-MAY-2021 contains no new information.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-080115:First Dose
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Severe pain shooting up her neck; Felt hot and cold; Sore throat; Developed a rash on her arm that then spread to the larger area of it; Severe migraine pain; slight headache; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Severe migraine pain), NECK PAIN (Severe pain shooting up her neck), FEELING OF BODY TEMPERATURE CHANGE (Felt hot and cold), OROPHARYNGEAL PAIN (Sore throat) and RASH (Developed a rash on her arm that then spread to the larger area of it) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027B21A and 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEADACHE (slight headache). On 16-Apr-2021, the patient experienced MIGRAINE (Severe migraine pain). On 17-Apr-2021, the patient experienced RASH (Developed a rash on her arm that then spread to the larger area of it). On an unknown date, the patient experienced NECK PAIN (Severe pain shooting up her neck), FEELING OF BODY TEMPERATURE CHANGE (Felt hot and cold) and OROPHARYNGEAL PAIN (Sore throat). At the time of the report, MIGRAINE (Severe migraine pain), NECK PAIN (Severe pain shooting up her neck), FEELING OF BODY TEMPERATURE CHANGE (Felt hot and cold), OROPHARYNGEAL PAIN (Sore throat) and HEADACHE (slight headache) outcome was unknown and RASH (Developed a rash on her arm that then spread to the larger area of it) had not resolved.            No concomitant medication was reported. No treatment medication was reported.  Action taken with the mRNA-1273 vaccine in response to the events was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-080115 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 16-May-2021: Initial additional (TCR) received on 16-MAY-2021 contains no new information.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-080115:First Dose
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Product administration error, Vaccination site bruising, Vaccination site haemorrhage
Clinical narrative: unsure if the HCP injected her in the right location; blood dripped down; yellowish bruise near injection site; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTRATION ERROR (unsure if the HCP injected her in the right location), VACCINATION SITE HAEMORRHAGE (blood dripped down) and VACCINATION SITE BRUISING (yellowish bruise near injection site) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, the patient experienced PRODUCT ADMINISTRATION ERROR (unsure if the HCP injected her in the right location), VACCINATION SITE HAEMORRHAGE (blood dripped down) and VACCINATION SITE BRUISING (yellowish bruise near injection site). On 05-Apr-2021, PRODUCT ADMINISTRATION ERROR (unsure if the HCP injected her in the right location) had resolved. At the time of the report, VACCINATION SITE HAEMORRHAGE (blood dripped down) and VACCINATION SITE BRUISING (yellowish bruise near injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications taken by the patient were not provided. Treatment activities for event was done with ice, topical CBD (cannabidiol).
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vaccination site erythema, Vaccination site rash, Vaccination site swelling
Clinical narrative: Swelling at the injection site; Redness at the injection site; Rash in the upper arm; Slight headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site), VACCINATION SITE RASH (Rash in the upper arm) and HEADACHE (Slight headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. Unknown and Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 17-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Apr-2021, the patient experienced VACCINATION SITE SWELLING (Swelling at the injection site). 17-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness at the injection site), VACCINATION SITE RASH (Rash in the upper arm) and HEADACHE (Slight headache). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, VACCINATION SITE SWELLING (Swelling at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site), VACCINATION SITE RASH (Rash in the upper arm) and HEADACHE (Slight headache) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  Concomitant medication not provided.  Treatment included wet/cold rags on the inflammation area.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Left arm still sore off and on after 4 weeks from 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Left arm still sore off and on after 4 weeks from 1st dose) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included TAMSULOSIN for an unknown indication.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Left arm still sore off and on after 4 weeks from 1st dose). At the time of the report, VACCINATION SITE PAIN (Left arm still sore off and on after 4 weeks from 1st dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product included eye drops (unspecified).  No treatment information was provided.   This case was linked to MOD-2021-148079 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: The follow up received on 17-May-2021, contains information: added primary reporter details, additional reporter, date of administration of first dose and concomitant medications were added.
Sex: U
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Chronic Headache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an attorney and describes the occurrence of HEADACHE (Chronic Headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Chronic Headache). At the time of the report, HEADACHE (Chronic Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication not provided.  Treatment information not provided.  On 19/Apr/2021, a lawyer reported that 13 other people have had chronic headache since receiving the vaccine.   This case was linked to MOD21-078107, MOD21-033662, MOD21-078198, US-MODERNATX, INC.-MOD-2021-080204, MOD-2021-015967 (E2B Linked Report).; Sender's Comments:  MOD21-078107: MOD21-033662: MOD21-078198: US-MODERNATX, INC.-MOD-2021-080204:MOD21-078196 MOD-2021-015967:Initial report
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Dry skin, Feeling abnormal, Paraesthesia, Skin reaction
Clinical narrative: A spot in her leg that is still sore to the touch; She felt on the right side of her leg between her knee and ankle like many bee stings; Her skin was tingling; Dry skin; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (She felt on the right side of her leg between her knee and ankle like many bee stings), PARAESTHESIA (Her skin was tingling), DRY SKIN (Dry skin) and SKIN REACTION (A spot in her leg that is still sore to the touch) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder NOS and Blood pressure abnormal. Concomitant products included CETIRIZINE for an unknown indication.    On 16-Apr-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FEELING ABNORMAL (She felt on the right side of her leg between her knee and ankle like many bee stings), PARAESTHESIA (Her skin was tingling) and DRY SKIN (Dry skin). On an unknown date, the patient experienced SKIN REACTION (A spot in her leg that is still sore to the touch). The patient was treated with AVENA SATIVA FLUID EXTRACT (AVEENO) at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (She felt on the right side of her leg between her knee and ankle like many bee stings), PARAESTHESIA (Her skin was tingling), DRY SKIN (Dry skin) and SKIN REACTION (A spot in her leg that is still sore to the touch) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications also included thyroid pill, inhaler, blood pressure pill
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Inappropriate schedule of product administration, SARS-CoV-2 test positive
Clinical narrative: Second dose not given within 42 days from the initial dose, scheduled for 19 Apr 2021; Diagnosed withcovid-19 infection; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Diagnosed withcovid-19 infection) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose not given within 42 days from the initial dose, scheduled for 19 Apr 2021) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes and Hypertension. Concomitant products included INSULIN for Diabetes.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced COVID-19 (Diagnosed withcovid-19 infection). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose not given within 42 days from the initial dose, scheduled for 19 Apr 2021). At the time of the report, COVID-19 (Diagnosed withcovid-19 infection) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose not given within 42 days from the initial dose, scheduled for 19 Apr 2021) had resolved. Unknown    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Mar-2021, SARS-CoV-2 test positive: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products include medication for high blood pressure. No treatment information was provided.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site rash
Clinical narrative: big white circle in the arm of where the injection site and it has the diameter of 1.5 inches; painful right after the shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (painful right after the shot) and VACCINATION SITE RASH (big white circle in the arm of where the injection site and it has the diameter of 1.5 inches) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced VACCINATION SITE PAIN (painful right after the shot). On 19-Apr-2021, the patient experienced VACCINATION SITE RASH (big white circle in the arm of where the injection site and it has the diameter of 1.5 inches). At the time of the report, VACCINATION SITE PAIN (painful right after the shot) was resolving and VACCINATION SITE RASH (big white circle in the arm of where the injection site and it has the diameter of 1.5 inches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 08-Apr-2021, patient experienced painful right after the shot until 19-Apr-2021, the pain becomes dull. Patient stated that no medication was taken for the pain. Concomitant medications were not provided.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Dysstasia, Eye pain, Headache, Nausea, Retching
Clinical narrative: vertigo; Unable to stand; nausea; headache on the surface of her skull and behind her eyes/head pain; dry heaving; a painful headache on the surface of skull and behind eyes; This spontaneous case was reported by a consumer and describes the occurrence of EYE PAIN (a painful headache on the surface of skull and behind eyes), VERTIGO (vertigo), RETCHING (dry heaving), DYSSTASIA (Unable to stand) and NAUSEA (nausea) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Sinusitis and Vertigo. Concurrent medical conditions included Drug allergy (Jenuvia.) and Type 2 diabetes mellitus. Concomitant products included METFORMIN and LIRAGLUTIDE (VICTOZA) for Type 2 diabetes mellitus, MULTI VITAMINS & MINERALS and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Apr-2021, the patient experienced EYE PAIN (a painful headache on the surface of skull and behind eyes), RETCHING (dry heaving), NAUSEA (nausea) and HEADACHE (headache on the surface of her skull and behind her eyes/head pain). On 12-Apr-2021, the patient experienced VERTIGO (vertigo) and DYSSTASIA (Unable to stand). The patient was treated with PARACETAMOL at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, EYE PAIN (a painful headache on the surface of skull and behind eyes), RETCHING (dry heaving), DYSSTASIA (Unable to stand) and NAUSEA (nausea) outcome was unknown and VERTIGO (vertigo) and HEADACHE (headache on the surface of her skull and behind her eyes/head pain) had resolved.            Action taken with mRNA-1273 in response to the event was not applicable.    Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: Follow-up information received on 17 May 2021 contains significant information- updated height, weight, race, ethnic group, medical history, patient route of administration and indication of the concomitant drugs metformin and victoza. The onset date of event vertigo changed from 11 Apr 2021 to 12 Apr 2021 and outcome changed from unknown to recovered. The outcome of the event headache/head pain changed from unknown to recovered.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: vertigo; Unable to stand; nausea; headache on the surface of her skull and behind her eyes/head pain; dry heaving; a painful headache on the surface of skull and behind eyes; This spontaneous case was reported by a consumer and describes the occurrence of EYE PAIN (a painful headache on the surface of skull and behind eyes), VERTIGO (vertigo), RETCHING (dry heaving), DYSSTASIA (Unable to stand) and NAUSEA (nausea) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Sinusitis and Vertigo. Concurrent medical conditions included Drug allergy (Jenuvia.) and Type 2 diabetes mellitus. Concomitant products included METFORMIN and LIRAGLUTIDE (VICTOZA) for Type 2 diabetes mellitus, MULTI VITAMINS & MINERALS and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Apr-2021, the patient experienced EYE PAIN (a painful headache on the surface of skull and behind eyes), RETCHING (dry heaving), NAUSEA (nausea) and HEADACHE (headache on the surface of her skull and behind her eyes/head pain). On 12-Apr-2021, the patient experienced VERTIGO (vertigo) and DYSSTASIA (Unable to stand). The patient was treated with PARACETAMOL at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, EYE PAIN (a painful headache on the surface of skull and behind eyes), RETCHING (dry heaving), DYSSTASIA (Unable to stand) and NAUSEA (nausea) outcome was unknown and VERTIGO (vertigo) and HEADACHE (headache on the surface of her skull and behind her eyes/head pain) had resolved.            Action taken with mRNA-1273 in response to the event was not applicable.    Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: Follow-up information received on 17 May 2021 contains significant information- updated height, weight, race, ethnic group, medical history, patient route of administration and indication of the concomitant drugs metformin and victoza. The onset date of event vertigo changed from 11 Apr 2021 to 12 Apr 2021 and outcome changed from unknown to recovered. The outcome of the event headache/head pain changed from unknown to recovered.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headaches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headaches) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced HEADACHE (headaches). At the time of the report, HEADACHE (headaches) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments  Concomitant medications not provided. Treatment information not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-080102; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-080102:second dose of the same patient
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Diarrhoea, Dizziness, Feeling hot
Clinical narrative: sweating - cloths were soaking wet - sweating in bucket; dizzy; so weak; deathly sick; got really really hot; little bit of diarrhea; not really a headache but just pressure; really nauseated; headache; chills; This spontaneous case was reported by a patient and describes the occurrence of HYPERHIDROSIS (sweating - cloths were soaking wet - sweating in bucket), DIZZINESS (dizzy), ASTHENIA (so weak), ILLNESS (deathly sick) and FEELING HOT (got really really hot) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 027B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 07-Apr-2021, the patient experienced HYPERHIDROSIS (sweating - cloths were soaking wet - sweating in bucket), DIZZINESS (dizzy), ASTHENIA (so weak), ILLNESS (deathly sick), FEELING HOT (got really really hot), DIARRHOEA (little bit of diarrhea), HEAD DISCOMFORT (not really a headache but just pressure), NAUSEA (really nauseated), HEADACHE (headache) and CHILLS (chills). At the time of the report, HYPERHIDROSIS (sweating - cloths were soaking wet - sweating in bucket), DIZZINESS (dizzy), ASTHENIA (so weak), ILLNESS (deathly sick), FEELING HOT (got really really hot), DIARRHOEA (little bit of diarrhea), HEAD DISCOMFORT (not really a headache but just pressure), NAUSEA (really nauseated), HEADACHE (headache) and CHILLS (chills) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments  No concomitant medications were provided. Treatment medications was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-079972 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-079972:Crossed linked
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Head discomfort, Headache, Hyperhidrosis, Illness, Nausea
Clinical narrative: sweating - cloths were soaking wet - sweating in bucket; dizzy; so weak; deathly sick; got really really hot; little bit of diarrhea; not really a headache but just pressure; really nauseated; headache; chills; This spontaneous case was reported by a patient and describes the occurrence of HYPERHIDROSIS (sweating - cloths were soaking wet - sweating in bucket), DIZZINESS (dizzy), ASTHENIA (so weak), ILLNESS (deathly sick) and FEELING HOT (got really really hot) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 027B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 07-Apr-2021, the patient experienced HYPERHIDROSIS (sweating - cloths were soaking wet - sweating in bucket), DIZZINESS (dizzy), ASTHENIA (so weak), ILLNESS (deathly sick), FEELING HOT (got really really hot), DIARRHOEA (little bit of diarrhea), HEAD DISCOMFORT (not really a headache but just pressure), NAUSEA (really nauseated), HEADACHE (headache) and CHILLS (chills). At the time of the report, HYPERHIDROSIS (sweating - cloths were soaking wet - sweating in bucket), DIZZINESS (dizzy), ASTHENIA (so weak), ILLNESS (deathly sick), FEELING HOT (got really really hot), DIARRHOEA (little bit of diarrhea), HEAD DISCOMFORT (not really a headache but just pressure), NAUSEA (really nauseated), HEADACHE (headache) and CHILLS (chills) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments  No concomitant medications were provided. Treatment medications was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-079972 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-079972:Crossed linked
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030821A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported  treatment information was not provided.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Decreased appetite, Dizziness, Fatigue
Clinical narrative: Numb lips; Severe migraine headache; Dizziness / Lightheaded; No apetite; Joint pain; Muscle ache; Nausea; Fatigue; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (Numb lips), MIGRAINE (Severe migraine headache), DIZZINESS (Dizziness / Lightheaded), DECREASED APPETITE (No apetite) and ARTHRALGIA (Joint pain) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Bee sting (Bee allergy).   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced HYPOAESTHESIA ORAL (Numb lips), MIGRAINE (Severe migraine headache), DIZZINESS (Dizziness / Lightheaded), DECREASED APPETITE (No apetite), ARTHRALGIA (Joint pain), MYALGIA (Muscle ache), NAUSEA (Nausea), FATIGUE (Fatigue), CHILLS (Chills) and PYREXIA (Fever). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. On 15-Apr-2021, HYPOAESTHESIA ORAL (Numb lips) had resolved. At the time of the report, MIGRAINE (Severe migraine headache), DIZZINESS (Dizziness / Lightheaded), DECREASED APPETITE (No apetite), ARTHRALGIA (Joint pain), MYALGIA (Muscle ache), NAUSEA (Nausea), FATIGUE (Fatigue), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown. Not Provided          No concomitant medications were reported.  Patient has an allergy to bees, therefore carries an EpiPen.   This case was linked to MOD21-077838, US-MODERNATX, INC.-MOD-2021-080159, US-MODERNATX, INC.-MOD-2021-080175 (E2B Linked Report).; Sender's Comments:  MOD21-077838:wife's case crosslinked US-MODERNATX, INC.-MOD-2021-080159:Husband's case crosslinked US-MODERNATX, INC.-MOD-2021-080175:Wife's case crosslinked
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Migraine, Myalgia, Nausea, Pyrexia
Clinical narrative: Numb lips; Severe migraine headache; Dizziness / Lightheaded; No apetite; Joint pain; Muscle ache; Nausea; Fatigue; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (Numb lips), MIGRAINE (Severe migraine headache), DIZZINESS (Dizziness / Lightheaded), DECREASED APPETITE (No apetite) and ARTHRALGIA (Joint pain) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Bee sting (Bee allergy).   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced HYPOAESTHESIA ORAL (Numb lips), MIGRAINE (Severe migraine headache), DIZZINESS (Dizziness / Lightheaded), DECREASED APPETITE (No apetite), ARTHRALGIA (Joint pain), MYALGIA (Muscle ache), NAUSEA (Nausea), FATIGUE (Fatigue), CHILLS (Chills) and PYREXIA (Fever). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. On 15-Apr-2021, HYPOAESTHESIA ORAL (Numb lips) had resolved. At the time of the report, MIGRAINE (Severe migraine headache), DIZZINESS (Dizziness / Lightheaded), DECREASED APPETITE (No apetite), ARTHRALGIA (Joint pain), MYALGIA (Muscle ache), NAUSEA (Nausea), FATIGUE (Fatigue), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown. Not Provided          No concomitant medications were reported.  Patient has an allergy to bees, therefore carries an EpiPen.   This case was linked to MOD21-077838, US-MODERNATX, INC.-MOD-2021-080159, US-MODERNATX, INC.-MOD-2021-080175 (E2B Linked Report).; Sender's Comments:  MOD21-077838:wife's case crosslinked US-MODERNATX, INC.-MOD-2021-080159:Husband's case crosslinked US-MODERNATX, INC.-MOD-2021-080175:Wife's case crosslinked
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Headache, Pain in extremity
Clinical narrative: dark bruise on breast; Headache; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), CONTUSION (dark bruise on breast) and HEADACHE (Headache) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 037A21B) for COVID-19 vaccination.     Concurrent medical conditions included Breast cancer (Right breast). Concomitant products included ANASTROZOLE, METFORMIN, PRAVASTATIN, PROPRANOLOL (PROPANOLOL [PROPRANOLOL]) and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and HEADACHE (Headache). On 16-Apr-2021, the patient experienced CONTUSION (dark bruise on breast). At the time of the report, PAIN IN EXTREMITY (Sore arm), CONTUSION (dark bruise on breast) and HEADACHE (Headache) outcome was unknown.            No treatment information was provided. ? The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the mRNA-1273 in response to the events was not applicable. ? Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: Updated patient email address
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Gastrointestinal disorder, Headache, Influenza virus test, Nausea, SARS-CoV-2 test
Clinical narrative: Gastrointestinal Problems; Severe Headache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of GASTROINTESTINAL DISORDER (Gastrointestinal Problems), HEADACHE (Severe Headache) and NAUSEA (Nausea) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, the patient experienced GASTROINTESTINAL DISORDER (Gastrointestinal Problems), HEADACHE (Severe Headache) and NAUSEA (Nausea). At the time of the report, GASTROINTESTINAL DISORDER (Gastrointestinal Problems), HEADACHE (Severe Headache) and NAUSEA (Nausea) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Influenza virus test: negative (Negative) Negative. On an unknown date, SARS-CoV-2 test: negative (Negative) Negative. On an unknown date, Streptococcus test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Streptococcus test
Clinical narrative: Gastrointestinal Problems; Severe Headache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of GASTROINTESTINAL DISORDER (Gastrointestinal Problems), HEADACHE (Severe Headache) and NAUSEA (Nausea) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, the patient experienced GASTROINTESTINAL DISORDER (Gastrointestinal Problems), HEADACHE (Severe Headache) and NAUSEA (Nausea). At the time of the report, GASTROINTESTINAL DISORDER (Gastrointestinal Problems), HEADACHE (Severe Headache) and NAUSEA (Nausea) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Influenza virus test: negative (Negative) Negative. On an unknown date, SARS-CoV-2 test: negative (Negative) Negative. On an unknown date, Streptococcus test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Low body temperature; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Low body temperature) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045B21A and 008B21-2A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PYREXIA (Low body temperature). At the time of the report, PYREXIA (Low body temperature) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Apr-2021, Body temperature: 96.6 (normal) normal.         No concomitant product use was reported.  No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not applicable.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea, Joint swelling, Lymphadenopathy, Myalgia
Clinical narrative: shortness of breath; Tightness in chest; Muscle soreness; Swollen joints; Swollen lymph nodes; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Muscle soreness), JOINT SWELLING (Swollen joints), LYMPHADENOPATHY (Swollen lymph nodes), NAUSEA (Nausea) and DYSPNOEA (shortness of breath) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Rheumatoid arthritis and Asthma. Concurrent medical conditions included Penicillin allergy.   On 16-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, the patient experienced MYALGIA (Muscle soreness), JOINT SWELLING (Swollen joints), LYMPHADENOPATHY (Swollen lymph nodes) and NAUSEA (Nausea). On 18-Apr-2021, the patient experienced DYSPNOEA (shortness of breath) and CHEST DISCOMFORT (Tightness in chest). The patient was treated with ALBUTEROL [SALBUTAMOL] ongoing since an unknown date at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. On 19-Apr-2021, MYALGIA (Muscle soreness), JOINT SWELLING (Swollen joints) and NAUSEA (Nausea) had resolved. At the time of the report, LYMPHADENOPATHY (Swollen lymph nodes), DYSPNOEA (shortness of breath) and CHEST DISCOMFORT (Tightness in chest) outcome was unknown.            Relevant concomitant product usage were not reported by the reporter.  Action taken with mRNA-1273 in response to the event was not applicable.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: shortness of breath; Tightness in chest; Muscle soreness; Swollen joints; Swollen lymph nodes; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Muscle soreness), JOINT SWELLING (Swollen joints), LYMPHADENOPATHY (Swollen lymph nodes), NAUSEA (Nausea) and DYSPNOEA (shortness of breath) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Rheumatoid arthritis and Asthma. Concurrent medical conditions included Penicillin allergy.   On 16-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, the patient experienced MYALGIA (Muscle soreness), JOINT SWELLING (Swollen joints), LYMPHADENOPATHY (Swollen lymph nodes) and NAUSEA (Nausea). On 18-Apr-2021, the patient experienced DYSPNOEA (shortness of breath) and CHEST DISCOMFORT (Tightness in chest). The patient was treated with ALBUTEROL [SALBUTAMOL] ongoing since an unknown date at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. On 19-Apr-2021, MYALGIA (Muscle soreness), JOINT SWELLING (Swollen joints) and NAUSEA (Nausea) had resolved. At the time of the report, LYMPHADENOPATHY (Swollen lymph nodes), DYSPNOEA (shortness of breath) and CHEST DISCOMFORT (Tightness in chest) outcome was unknown.            Relevant concomitant product usage were not reported by the reporter.  Action taken with mRNA-1273 in response to the event was not applicable.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included IBUPROFEN for an unknown indication.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Treatment medications included ibuprofen.   This case was linked to MOD21-078128, US-MODERNATX, INC.-MOD-2021-080143 (E2B Linked Report).; Sender's Comments:  MOD21-078128:Husband report US-MODERNATX, INC.-MOD-2021-080143:2nd Dose Case
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Neck pain, Pain, Pain in extremity
Clinical narrative: Upper arm, back, neck and above shoulder started aching; Whole torso was aching.; Back, neck and above shoulder started aching; Neck and above shoulder started aching; Shoulder started aching; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Upper arm, back, neck and above shoulder started aching), PAIN (Whole torso was aching.), BACK PAIN (Back, neck and above shoulder started aching), NECK PAIN (Neck and above shoulder started aching) and ARTHRALGIA (Shoulder started aching) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M02A) for COVID-19 vaccination.     The patient's past medical history included Surgery (Implantation for Vagus Nerve Stimulation therapy). Concurrent medical conditions included Epilepsy (Patient states that she has not had an episode in two years.).    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced PAIN IN EXTREMITY (Upper arm, back, neck and above shoulder started aching), PAIN (Whole torso was aching.), BACK PAIN (Back, neck and above shoulder started aching), NECK PAIN (Neck and above shoulder started aching) and ARTHRALGIA (Shoulder started aching). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at a dose of UNK dosage form. On 01-Mar-2021, PAIN IN EXTREMITY (Upper arm, back, neck and above shoulder started aching), PAIN (Whole torso was aching.), BACK PAIN (Back, neck and above shoulder started aching), NECK PAIN (Neck and above shoulder started aching) and ARTHRALGIA (Shoulder started aching) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-080144 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 17-Jun-2021: Follow up received. No significant information added.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-080144:2nd Dose
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Epistaxis, Fatigue
Clinical narrative: bloody noses; fatigue; chills; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (bloody noses), FATIGUE (fatigue) and CHILLS (chills) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse drug reaction (medical history was not provided).    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced EPISTAXIS (bloody noses), FATIGUE (fatigue) and CHILLS (chills). At the time of the report, EPISTAXIS (bloody noses), FATIGUE (fatigue) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: Non Significant follow-up
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Sensitive skin, Skin swelling, Vomiting
Clinical narrative: Swollen skin underneath Eyes; Skin sensitive to the touch underneath her eyes; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of SKIN SWELLING (Swollen skin underneath Eyes), SENSITIVE SKIN (Skin sensitive to the touch underneath her eyes) and VOMITING (Vomiting) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 026A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Apr-2021, the patient experienced SKIN SWELLING (Swollen skin underneath Eyes), SENSITIVE SKIN (Skin sensitive to the touch underneath her eyes) and VOMITING (Vomiting). At the time of the report, SKIN SWELLING (Swollen skin underneath Eyes), SENSITIVE SKIN (Skin sensitive to the touch underneath her eyes) and VOMITING (Vomiting) outcome was unknown. Not Provided          No concomitant medication details was reported. No treatment medication details was reported. Action taken with mRNA-1273 in response to the events was not applicable.